Damora Therapeutics (DMRA) Return on Capital Employed [ROCE] (2020 - 2026)
Damora Therapeutics' Return on Capital Employed [ROCE] was -52.87% in Q2 2026, up 89.68 percentage points from -142.55% a year earlier and up 11.03 percentage points from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Damora Therapeutics came in at -177.61%, down 93.54 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for five consecutive years, with a five-year change of -146.61 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -84.07% in FY2024 (-4.06 pp), -80.01% in FY2023 (-9.32 pp), -70.68% in FY2022 (-34.00 pp) and -36.69% in FY2021 (-5.69 pp).
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q1 2022.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in three of the last eight quarters, with an average year-over-year change of -5.99 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 89.68 percentage points); the worst was Q3 2025 (a drop of 74.39 percentage points).
- Per Business Quant data, DMRA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -63.90% (Q1 2026), -182.52% (Q4 2025) and -169.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Damora Therapeutics | 1.27 Bn | -63.83 Mn | - | -52.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -52.87% |
| Mar 31, 2026 | -63.90% |
| Dec 31, 2025 | -182.52% |
| Sep 30, 2025 | -169.73% |
| Jun 30, 2025 | -142.55% |
| Mar 31, 2025 | -130.51% |
| Dec 31, 2024 | -116.83% |
| Sep 30, 2024 | -95.34% |
| Jun 30, 2024 | -101.51% |
| Mar 31, 2024 | -103.61% |
| Dec 31, 2023 | -104.17% |
| Sep 30, 2023 | -111.79% |
| Jun 30, 2023 | -110.64% |
| Mar 31, 2023 | -105.38% |
| Dec 31, 2022 | -92.04% |
| Sep 30, 2022 | -77.86% |
| Jun 30, 2022 | -64.74% |
| Mar 31, 2022 | -51.32% |
| Dec 31, 2021 | -41.95% |
| Sep 30, 2021 | -36.92% |
API Access
Damora Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();